Adaptin Bio, Inc.
APTN
$6.20
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 167.38% | 388.49% | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 82.94% | 110.72% | -- | -- | -- |
| Operating Income | -82.94% | -110.72% | -- | -- | -- |
| Income Before Tax | -68.64% | -65.50% | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -68.64% | -65.50% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -68.64% | -65.50% | -- | -- | -- |
| EBIT | -82.94% | -110.72% | -- | -- | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 30.08% | 33.08% | -- | -- | -- |
| Normalized Basic EPS | 29.81% | 22.43% | -- | -- | -- |
| EPS Diluted | 29.82% | 32.82% | -- | -- | -- |
| Normalized Diluted EPS | 29.81% | 22.43% | -- | -- | -- |
| Average Basic Shares Outstanding | 118.88% | 140.15% | -- | -- | -- |
| Average Diluted Shares Outstanding | 118.88% | 140.15% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |